Natasha Rego

Finance Manager at Hvivo

Natasha Rego's Professional Contact Details

Email (Verified)

****

Get Email Address

Company

Hvivo

Person Seniority

manager

Person Functions

finance

Natasha Rego's Current Company Details

Hvivo

London, England, United Kingdom • 203 Employees

biotechnology

Welcome to hVIVO.... better treatments, faster hVIVO, a specialty biopharma company with clinical testing capabilities, is pioneering a human-based analytical platform to accelerate drug discovery and development in respiratory and infectious diseases. hVIVO changed its name from Retroscreen Virology in April 2015. The business is a plc quoted on the AIM London Stock Exchange (ticker â€˜HVO'). Leveraging human disease models in flu, RSV, and asthma exacerbation, the hVIVO platform captures â€˜disease in motion', illuminating the entire disease life cycle from healthy to sick and back to health. Via this insight, the platform enables the rational selection of drug targets and biomarkers while simultaneously providing a revolutionary methodology for testing product safety and efficacy. The Company has three clinical stage products currently in development as well as a growing pre-clinical pipeline. Our belief is that real people hold the key to understanding human biology and this radically simple concept is opening up a brave new world of breakthrough science. hVIVO has established itself as the world leader in human challenge models. Visit our career pages at www.hvivo.com/careers to see our current openings.

Public Symbol

HVO

Founded Year

1998

Organization Website

hvivo.com

Organization Languages

English

Current Technologies

office 365

linkedin display ads formerly bizo

facebook login